NCT02689258View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

277

Participants

Timeline

Start Date

February 23, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Postoperative Pain
Interventions
DRUG

HTX-011B

HTX- 011B (bupivacaine/meloxicam) via injection

DRUG

Placebo

Saline placebo via injection

DRUG

HTX-011A

HTX- 011A (bupivacaine/meloxicam) via injection

DRUG

HTX-002

HTX-002 via combination

DRUG

Bupivicaine HCl

Bupivacaine HCl via injection

Trial Locations (8)

21122

Pasadena

75093

Plano

77004

Houston

77019

Houston

77027

Houston

77401

Bellaire

85023

Phoenix

91105

Pasadena

Sponsors

Lead Sponsor

Heron Therapeutics
All Listed Sponsors
lead

Heron Therapeutics

INDUSTRY